Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)
Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
This study is no longer accepting new participants.
In Pittsburgh
Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Cognitive Enhancement for Persistent Negative Symptoms in Schizophrenia
This study is no longer accepting new participants.
In PittsburghPromoting Cognitive Health in Schizophrenia: A National Collaborative Effort to Implement Online Psychological Interventions
This study has finished and is no longer accepting participants.
Multiple locations, including VancouverThis study is no longer accepting new participants.
In PhoenixThis study has finished and is no longer accepting participants.
In DijonThis study evaluated the effectiveness of Raloxifene for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including SabadellThis study evaluated the safety and effectiveness of LB-102 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleThis study has finished and is no longer accepting participants.
In TorontoReal-life Assessment of Aripiprazole Long-acting Injection (Abilify Maintena) Combined With Brexpiprazole (Rexulti) in Schizophrenia: a Naturalistic Non-interventional Prospective Follow-up Study
This study has finished and is no longer accepting participants.
In Hong KongThis study has finished and is no longer accepting participants.
In AuroraA Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Prevention of Relapse in Patients With Schizophrenia Receiving Either Flexible Dose Iloperidone or Placebo in Long-term Use (up to 26 Weeks) Followed by up to 52 Weeks of Open-label Extension
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimThis study has finished and is no longer accepting participants.
In MinneapolisRepetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms on Schizophrenia: Controlled, Randomised, Double Blind Trial
This study has finished and is no longer accepting participants.
In ColombesWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.